Yesterday, The Cap Times reported on Wisconsin GOP U.S. Senator Ron Johnson’s voting last week against the passage of the Inflation Reduction Act, and his attack on “an effort to ensure that people with diabetes could afford life-saving insulin.”
Johnson is in it for himself and the billionaire Big Pharma backers who have bought his vote. Wisconsinites are tired of having a senator who puts his personal interests ahead of the needs of those he represents.
The Cap Times: Opinion | Ron Johnson is so cruel that he won’t even help diabetics pay for insulin
By John Nichols | August 9, 2022
Key Points:
-
“Wisconsin Sen. Ron Johnson voted last week to block passage of the Inflation Reduction Act, the modest proposal to tax corporations a bit more fairly and use the money to expand access to health care and address climate change. No surprise there. Johnson’s against fair taxation, he’s never shown much interest in meeting human needs and he could care less about the planet. In other words, he’s a Republican partisan not unlike the other sorry members of Senate Minority Leader Mitch McConnell’s wrecking crew caucus.”
-
“But Johnson stood out as the cruelest member of that caucus when he broke with chamber’s Democrats and even a number of his fellow Republicans to bitterly attack an effort to ensure that people with diabetes could afford life-saving insulin. Displaying the venomous dishonesty for which he has become known, Johnson dismissed the concerns of millions of Americans who were pleading for federal intervention to prevent drug company price gouging.”
-
“I[t] was a sincere effort to save lives by making sure that people with diabetes don’t have to ration insulin. Seven Senate Republicans recognized that reality. But Johnson still went on the attack. Johnson’s the liar. And in this case he’s the cruelest of all liars — a political careerist who claims that an effort to save lives is “all for show.” Johnson’s the one putting on the show. It’s time for the voters of Wisconsin to cancel him.”
Read the full report here.
